CD160 and neoplasm: As expected, 22B12 mAb allowed CD160-TM detection on paraffin-embedded or fixed cells, and more importantly on TNBC patients' tumor biopsies but not on healthy breast tissues, suggesting that it might represent a valuable tool for TNBC pre-therapeutic phenotyping.